menu
    • menu

    Find Efinaconazole manufacturers, exporters & distributors on PharmaCompass

    Virupaksha Efinaconazole

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    31

    API Suppliers

    API Suppliers

    22

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    5

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    17

    KDMF

    KDMF

    14

    NDC API

    NDC API

    0

    VMF

    NDC API

    20

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 8,222

    MARKET PLACE

    12

    API

    0

    FDF

    4INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    9

    FDF Dossiers

    FDF Dossiers

    8

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    1

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    3DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    4

    Others

    PATENTS & EXCLUSIVITIES

    18

    US Patents

    0

    US Exclusivities

    2

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    37

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    69,225,105

    Annual Reports

    NA

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 164650-44-6, (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol, Kp-103, Jublia, Clenafin, Kp103
    Molecular Formula
    C18H22F2N4O
    Molecular Weight
    348.4  g/mol
    InChI Key
    NFEZZTICAUWDHU-RDTXWAMCSA-N
    FDA UNII
    J82SB7FXWB
    Efinaconazole
    Efinaconazole is a triazole compound, with antifungal activity. Upon administration, efinaconazole targets, binds to and inhibits 14-alpha-demethylase, a cytochrome P450-dependent enzyme. Inhibition of 14-alpha-demethylase prevents the conversion of lanosterol to ergosterol, an important component of the fungal cell wall. Inhibition of ergosterol synthesis changes the fungal cell membrane composition and integrity, alters membrane permeability and eventually leads to fungal cell lysis.
    Efinaconazole is an Azole Antifungal.
    1 2D Structure

    Efinaconazole

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
    2.1.2 InChI
    InChI=1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1
    2.1.3 InChI Key
    NFEZZTICAUWDHU-RDTXWAMCSA-N
    2.1.4 Canonical SMILES
    CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3
    2.1.5 Isomeric SMILES
    C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3
    2.2 Other Identifiers
    2.2.1 UNII
    J82SB7FXWB
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Jublia

    2. Kp 103

    3. Kp-103

    4. Kp103

    2.3.2 Depositor-Supplied Synonyms

    1. 164650-44-6

    2. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol

    3. Kp-103

    4. Jublia

    5. Clenafin

    6. Kp103

    7. Idp-108

    8. J82sb7fxwb

    9. 164905-19-5

    10. Chebi:82718

    11. (2r,3r)-2-(2,4-difluorofenil)-3-(4-metilenopiperidin-1-il)-1-(1h-1,2,4-triazin-1-il)butan-2-ol

    12. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol

    13. Efinaconazole [inn]

    14. Kp 103

    15. Unii-j82sb7fxwb

    16. Efinaconazole [usan:inn]

    17. Efinaconazol

    18. Efinaconazolum

    19. Clenafin (tn)

    20. Jublia (tn)

    21. Efinaconazole(kp-103)

    22. Efinaconazole; Kp-103

    23. Efinaconazole [mi]

    24. Efinaconazole [jan]

    25. Efinaconazole [usan]

    26. Efinaconazole [vandf]

    27. Schembl300738

    28. Efinaconazole [who-dd]

    29. Zinc6251

    30. Chembl2103877

    31. Efinaconazole (jan/usan/inn)

    32. Hsdb 8341

    33. Dtxsid40167787

    34. Efinaconazole [orange Book]

    35. Bcp11665

    36. Ex-a2643

    37. Mfcd00936406

    38. S5025

    39. Akos027323571

    40. Ccg-268012

    41. Cs-3500

    42. Db09040

    43. Ncgc00390702-01

    44. Ncgc00390702-02

    45. Ncgc00390702-03

    46. Ac-30630

    47. As-30126

    48. Hy-15660

    49. D10021

    50. A854585

    51. Q21011225

    52. (2r, 3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidyl)-1-(1,2,4-triazolyl)butan-2-ol

    53. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol

    54. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidyl)-1-(1,2,4-triazol-1-yl)butan-2-ol

    55. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1h-1,2,4-triazole-1-yl)butane-2-ol

    56. (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidino)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol

    57. (alphar,betar)-alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1h-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol

    58. 1-piperidineethanol, .alpha.-(2,4-difluorophenyl)-.beta.-methyl-4-methylene-.alpha.-(1h-1,2,4-triazol-1-ylmethyl)-, (r-(r*,r*))-

    59. 1-piperidineethanol, .alpha.-(2,4-difluorophenyl)-.beta.-methyl-4-methylene-.alpha.-(1h-1,2,4-triazol-1-ylmethyl)-,(.alpha.r,.beta.r)-

    60. 1-piperidineethanol, Alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1h-1,2,4-triazol-1- Ylmethyl)-, (alphar,betar)-

    61. 1-piperidineethanol, Alpha-(2,4-difluorophenyl)-beta-methyl-4-methylene-alpha-(1h-1,2,4-triazol-1-ylmethyl)-, (alphar,betar)-

    2.4 Create Date
    2005-08-01
    3 Chemical and Physical Properties
    Molecular Weight 348.4 g/mol
    Molecular Formula C18H22F2N4O
    XLogP32
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count5
    Exact Mass348.17616766 g/mol
    Monoisotopic Mass348.17616766 g/mol
    Topological Polar Surface Area54.2 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity470
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Therapeutic Uses

    Antifungal Agents

    National Library of Medicine's Medical Subject Headings. Efinaconazole. Online file (MeSH, 2016). Available from, as of June 24, 2016: https://www.nlm.nih.gov/mesh/2016/mesh_browser/MBrowser.html

    Jublia (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. /Included in US product label/

    NIH; DailyMed. Current Medication Information for Jublia (Efinaconazole) Solution (Updated: May 2016). Available from, as of July 5, 2016: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=922d4d25-c530-11e1-9b21-0800200c9a66

    We sought to evaluate the efficacy of efinaconazole topical solution, 10%, in patients with onychomycosis and coexisting tinea pedis. We analyzed 1,655 patients, aged 18 to 70 years, randomized (3:1) to receive efinaconazole topical solution, 10%, or vehicle from two identical multicenter, double-blind, vehicle-controlled 48-week studies evaluating safety and efficacy. The primary end point was complete cure rate (0% clinical involvement of the target toenail and negative potassium hydroxide examination and fungal culture findings) at week 52. Three groups were compared: patients with onychomycosis and coexisting interdigital tinea pedis on-study (treated or left untreated) and those with no coexisting tinea pedis. Treatment with efinaconazole topical solution, 10%, was significantly more effective than vehicle use irrespective of the coexistence of tinea pedis or its treatment. Overall, 352 patients with onychomycosis (21.3%) had coexisting interdigital tinea pedis, with 215 of these patients (61.1%) receiving investigator-approved topical antifungal agents for their tinea pedis in addition to their randomized onychomycosis treatment. At week 52, efinaconazole complete cure rates of 29.4% were reported in patients with onychomycosis when coexisting tinea pedis was treated compared with 16.1% when coexisting tinea pedis was not treated. Both cure rates were significant compared with vehicle (p = 0.003 and 0.045, respectively), and in the latter subgroup, no patients treated with vehicle achieved a complete cure. Treatment of coexisting tinea pedis in patients with onychomycosis enhances the efficacy of once-daily topical treatment with efinaconazole topical solution, 10%.

    PMID:26429609 Markinson B, Caldwell B; J Am Podiatr Med Assoc 105 (5): 407-11 (2015)

    A number of comorbidities and risk factors complicate the successful management of onychomycosis. Underlying conditions and patient characteristics, such as tinea pedis, age, and obesity, contribute to risk, whereas comorbidities, such as diabetes and psoriasis, can increase susceptibility to the disease. There are limited data on treatment effectiveness in these patients. Here, the authors review post hoc analyses of efinaconazole topical solution, 10%, in mild-to-moderate onychomycosis and present new data in terms of age and obesity. The only post hoc analysis to report significant differences so far is gender, where female patients do much better; however, the reasons are unclear. The authors report significant differences in terms of efficacy in obese patients who do not respond as well as those with normal body mass index (p=0.05) and in patients who have their co-existing tinea pedis treated compared to those in whom co-existing tinea pedis was not treated (p=0.025). Although there is a trend to reduced efficacy in older patients and those with co-existing diabetes, differences were not significant. More research is needed in onychomycosis patients with these important risk factors and comorbidities to fully evaluate the treatment challenges and possible solutions.

    PMID:26705439 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689496 Elewski BE, Tosti A; J Clin Aesthet Dermatol 8 (11): 38-42 (2015)

    Onychomycosis is a common fungal infection of the nail unit that results in discoloration, subungual debris, thickening, onycholysis, and often pain and impairment of mobility. Dermatophytomas are characterized by a thick fungal mass within and under the nail plate and are especially resistant to treatment. Here we report a case of a patient with a dermatophytoma who had failed oral terbinafine but was successfully treated with efinaconazole 10% topical solution.

    PMID:25942674 Cantrell W et al; J Drugs Dermatol 14 (5): 524-6 (2015)

    4.2 Drug Warning

    Adverse effects reported in at least 1% of adults treated with efinaconazole 10% topical solution and more frequently than with topical vehicle solution include application site dermatitis, ingrown toenail, application site vesicles, and application site pain.

    American Society of Health-System Pharmacists 2016; Drug Information 2016. Bethesda, MD. 2016

    Prior to treatment of onychomycosis, the diagnosis should be confirmed by direct microscopic examination of scrapings from infected toenails mounted in potassium hydroxide (KOH) or by culture.

    American Society of Health-System Pharmacists 2016; Drug Information 2016. Bethesda, MD. 2016

    Efinaconazole 10% solution is for topical use only. The topical solution should not be used orally or intravaginally, and should not be applied to the eyes.

    American Society of Health-System Pharmacists 2016; Drug Information 2016. Bethesda, MD. 2016

    Efinaconazole 10% topical solution may cause application site irritation (e.g., redness, swelling, burning, itching, blisters); there is no evidence to date that the solution causes contact sensitization.

    American Society of Health-System Pharmacists 2016; Drug Information 2016. Bethesda, MD. 2016

    For more Drug Warnings (Complete) data for Efinaconazole (10 total), please visit the HSDB record page.

    4.3 Drug Indication

    Indicated in the treatment of fungal infection of the nail, known as onychomycosis.

    FDA Label

    Treatment of onychomycosis

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    mean SD plasma Cmax on Day 28 of treatment: 0.67 0.37 ng/mL. mean SD AUC was 12.15 6.91 ng*h/mL.

    5.2 MeSH Pharmacological Classification

    Antifungal Agents

    Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    EFINACONAZOLE
    5.3.2 FDA UNII
    J82SB7FXWB
    5.3.3 Pharmacological Classes
    Azoles [CS]; Azole Antifungal [EPC]
    5.4 ATC Code

    D - Dermatologicals

    D01 - Antifungals for dermatological use

    D01A - Antifungals for topical use

    D01AC - Imidazole and triazole derivatives

    D01AC19 - Efinaconazole

    5.5 Absorption, Distribution and Excretion

    Administration of Jublia by the topical route leads to low systemic efinaconazole concentrations. Systemic absorption of efinaconazole in 18 patients with severe onychomycosis was determined after application of Jublia once daily for 28 days to patients' 10 toenails and adjacent skin. The concentration of efinaconazole in plasma was determined at multiple time points over the course of 24-hour periods on days 1, 14, and 28. Efinaconazole mean plasma Cmax on Day 28 was 0.67 ng/mL. The mean plasma concentration versus time profile was generally flat over the course of treatment. In onychomycosis patients, the steady state plasma concentration range was 0.1-1.5 ng/mL for efinaconazole and 0.2-7.5 ng/mL for H3 metabolite.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.9 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    /MILK/ Efinaconazole and or its metabolites were excreted in milk from lactating rats. The radioactivity concentration in milk was higher than that in plasma concentration for 24 hours after the administration of 14C-efinaconazole to lactating rats. However, the elimination half-life of the milk radioactivity was about one half of that of the plasma radioactivity, suggesting that efinaconazole or its metabolites was not retained in milk.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.17 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    /MILK/ It is not known whether efinaconazole is excreted in human milk.

    NIH; DailyMed. Current Medication Information for Jublia (Efinaconazole) Solution (Updated: May 2016). Available from, as of July 5, 2016: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=922d4d25-c530-11e1-9b21-0800200c9a66

    Efinaconazole penetrates through nails in vitro after Jublia administration, suggesting drug penetrations to the site of fungal infection in the nail and the nail bed, though clinical relevance is unknown. The penetration of Jublia was evaluated in an in vitro investigation after daily application of radiolabelled efinaconazole (10%) to human nails for 28 days at 55.1 uL/sq cm. After 28 days, the cumulative radioactivity in the receptor fluid and in the nail plate, on a percent basis of total administered radioactivity, was 0.03% and 0.16% (3.11 mg eq/g), respectively. The flux rate was relatively constant from Days 18 to 28, mean 1.40 ug eq/sq cm/day, suggesting steady state attainment.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.9 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    For more Absorption, Distribution and Excretion (Complete) data for Efinaconazole (8 total), please visit the HSDB record page.

    5.6 Metabolism/Metabolites

    Efinaconazole is extensively metabolized. It is oxidatively metabolized, cleaved and conjugated to glucuronic acid. The studies have identified 5 metabolites (H1, H2, H3, H4 and H5) of efinaconazole. In rats and minipigs, H3 was the major efinaconazole plasma metabolite, and its levels usually equaled or exceeded those of parent drug. The in vitro and in vivo metabolite profiles in nonclinical species were similar to human with no unique human metabolite(s).

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.17 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    Jublia (efinaconazole) is extensively metabolized through oxidative/reductive processes, with the potential of additional metabolite glucuronidation. Analysis of human plasma confirmed that H3 is the only major efinaconazole metabolite.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.10 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    Efinaconazole metabolites, but not parent drug, were excreted in the bile and urine of rats and dogs which suggests complete metabolism of efinaconazole prior to excretion. Most of the absorbed radioactivity was eliminated during the first 72 hours after dermal and SC dosing in urine and feces.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.17 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    5.7 Biological Half-Life

    29.9 hours in healthy patients.

    In a ... study of healthy volunteers, the plasma half-life of Jublia at day 10 following repeat treatment applications repeated to all 10 toenails was 29.9 hours.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.9 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    5.8 Mechanism of Action

    Efinaconazole is an azole antifungal. Efinaconazole inhibits fungal lanosterol 14-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes.

    Efinaconazole is a triazole antifungal agent. Efinaconazole inhibits fungal lanosterol 14alpha-demethylase involved in ergosterol biosynthesis. The accumulation of 14alpha-methyl sterols and subsequent loss of ergosterol in the fungi cell wall may be responsible for the fungistatic and fungicidal activity of efinaconazole. Efinaconazole is shown in vitro to be substantially adsorbed to keratin but keratin binding is weak. Efinaconazole's low keratin affinity is expected to result in increased availability of free drug to the nail infection site.

    Health Canada; Product Monograph for Jublia (Efinaconazole) Topical Solution, 10% w/w, Drug Identification Number (DIN): 02413388 p.9 (Date of Preparation: October 2, 2013). Available from, as of July 5, 2016: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng

    USDMF

    read-more
    read-more

    01

    Virupaksha Organics Ltd

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2018-06-28

    Pay. Date : 2018-05-11

    DMF Number : 31366

    Submission : 2017-01-19

    Status : Active

    Type : II

    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Wavelength Enterprises Ltd

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2016-07-28

    Pay. Date : 2016-05-26

    DMF Number : 30538

    Submission : 2016-05-31

    Status : Active

    Type : II

    Seqens Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dipharma Francis Srl

    Italy

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    03

    Dipharma Francis Srl

    Italy
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-10-10

    Pay. Date : 2017-07-25

    DMF Number : 31918

    Submission : 2017-08-02

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Medlab Asia & Asia Health
    Not Confirmed

    04

    Glenmark Life Sciences Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-04-21

    Pay. Date : 2017-03-13

    DMF Number : 30892

    Submission : 2016-09-30

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Harman Finochem Ltd

    India

    USDMF

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    05

    Harman Finochem Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2018-02-14

    Pay. Date : 2018-01-16

    DMF Number : 32033

    Submission : 2017-12-06

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Medlab Asia & Asia Health
    Not Confirmed

    06

    Kaken Pharmaceutical Co Ltd

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21870

    Submission : 2008-07-25

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Medlab Asia & Asia Health
    Not Confirmed

    07

    Kaken Pharmaceutical Co Ltd

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20533

    Submission : 2007-05-01

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Medlab Asia & Asia Health
    Not Confirmed

    08

    Kaken Pharmaceutical Co Ltd

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27081

    Submission : 2013-05-24

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Medlab Asia & Asia Health
    Not Confirmed

    09

    Lupin Manufacturing Solutions Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-06-06

    Pay. Date : 2017-04-27

    DMF Number : 31503

    Submission : 2017-04-14

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Medlab Asia & Asia Health
    Not Confirmed

    10

    Maithri Drugs Private Ltd

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-03-30

    Pay. Date : 2016-09-30

    DMF Number : 30420

    Submission : 2016-03-30

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    Cipla Limited

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Cipla Limited

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registration Number : 302MF10122

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400...

    Initial Date of Registration : 2020-10-05

    Latest Date of Registration : 2020-10-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Procos S. p. A.

    Italy
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Procos S. p. A.

    Italy
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registration Number : 305MF10015

    Registrant's Address : Via Matteotti 249,28062 CAMERI (NOVARA)/ITALY

    Initial Date of Registration : 2023-02-02

    Latest Date of Registration : 2023-02-02

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Topharman Shandong Co. ,Ltd

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Topharman Shandong Co. ,Ltd

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registration Number : 306MF10108

    Registrant's Address : 49 Wenshuibeilu, Xin\'an District, Anqiu City, Weifang City, Shandong Province, China

    Initial Date of Registration : 2024-08-07

    Latest Date of Registration : 2024-08-07

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Tianish Laboratories Private Limite...

    U.S.A
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Tianish Laboratories Private Limite...

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    Registration Number : 302MF10155

    Registrant's Address : Plot No. 564/A/22, Road No. 92, Jubilee Hills, Hyderabad-500096, Telangana, India

    Initial Date of Registration : 2020-12-18

    Latest Date of Registration : 2020-12-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Zhejiang Ausun Pharmaceutical Co. ,...

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Zhejiang Ausun Pharmaceutical Co. ,...

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registration Number : 305MF10025

    Registrant's Address : No. 5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Zhejiang, Ch...

    Initial Date of Registration : 2023-02-08

    Latest Date of Registration : 2023-11-15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EU WC

    read-more
    read-more

    01

    Cipla

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole IH

    Date of Issue : 2022-06-17

    Valid Till : 2025-08-04

    Written Confirmation Number : WC-0142n

    Address of the Firm : Plot. A-33, A-37/2/2 MIDC, Patalganga-410 220, Dist. Raigad, Maharashtra

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Glenmark Life Sciences

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Glenmark Life Sciences

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole (IH)

    Date of Issue : 2023-12-28

    Valid Till : 2026-12-28

    Written Confirmation Number : WC-0310

    Address of the Firm : Plot No. Z-103/l, Dahej SEZ, Phase ll, Dahej, Dist-Bharuch, Gujarat

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Maithri Drugs

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Maithri Drugs

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole (IH)

    Date of Issue : 2020-09-09

    Valid Till : 2023-06-28

    Written Confirmation Number : WC-0407

    Address of the Firm : Sy. No. 205, 222 to 226, IDA Bonthapally bonthapally Village Jinnaram mandal med...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Virupaksha Organics

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Toru Corporation

    Registration Date : 2023-02-21

    Registration Number : Su434-16-ND(2)

    Manufacturer Name : Virupaksha Organics Ltd

    Manufacturer Address : Sy. No.10, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana Sta...

    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Virupaksha Organics

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Aging Life Science Co., Ltd.

    Registration Date : 2020-07-14

    Registration Number : Su434-16-ND

    Manufacturer Name : Virupaksha Organics Limited ...

    Manufacturer Address : Sy. No.10, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana Sta...

    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Virupaksha Organics

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Klasia Co., Ltd.

    Registration Date : 2020-09-04

    Registration Number : Su434-16-ND(1)

    Manufacturer Name : Virupaksha Organics Limited ...

    Manufacturer Address : Sy. No.10, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana Sta...

    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Cipla

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Hiple Co., Ltd.

    Registration Date : 2022-04-27

    Registration Number : No. 496-27-ND(1)

    Manufacturer Name : Cipla Limited.

    Manufacturer Address : Plot NOS. A-2, A-33 & A-37/2/2, MIDC, Patalganga, Raigad 410220 Maharashtra State, In...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Cipla

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Cipla

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Dongwha Pharmaceutical Co., Ltd.

    Registration Date : 2022-08-03

    Registration Number : No. 496-27-ND(2)

    Manufacturer Name : Cipla Limited.

    Manufacturer Address : Plot NOS. A-2, A-33 & A-37/2/2, MIDC, Patalganga, Raigad 410220 Maharashtra State, In...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Daebong

    South Korea
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Daebong

    South Korea
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Daebong LS Co., Ltd.

    Registration Date : 2021-07-13

    Registration Number : 1867-4-ND

    Manufacturer Name : Daebong LS Co., Ltd.

    Manufacturer Address : 122B-9L, 123, Neungheodae-ro 649beon-gil, Namdong-gu, Incheon

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Glenmark Life Sciences

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Glenmark Life Sciences

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : M-Peak Korea Co., Ltd.

    Registration Date : 2021-11-10

    Registration Number : Number 812-16-ND

    Manufacturer Name : Glenmark Life Sciences Ltd

    Manufacturer Address : Plot No.Z-103/ I, DAHEJ SEZ Phase II, City : Dahej, District : Bharuch, Gujarat State...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Harman Finochem

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Harman Finochem

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Ace Biopharm Co., Ltd.

    Registration Date : 2021-03-23

    Registration Number : Su289-8-ND

    Manufacturer Name : Harman Finochem Limited

    Manufacturer Address : A-100, A-100/1, A-100/2 & D-1, MIDC Industrial Area, Shendra, Aurangabad -431 007, Ma...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Kaneka Corporation

    Japan
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Kaneka Corporation

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Dong-A ST Co., Ltd.

    Registration Date : 2022-09-01

    Registration Number : Number 247-17-ND

    Manufacturer Name : Kaneka Corporation Takasago ...

    Manufacturer Address : 1-8, Miyamae-machi, Takasago-cho, Takasago, Hyogo 676-8688, Japan

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Procos

    Italy
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Procos

    Italy
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    Registrant Name : Sungjin Exim Co., Ltd.

    Registration Date : 2021-02-05

    Registration Number : 133-12-ND

    Manufacturer Name : Procos SpA

    Manufacturer Address : Via Matteotti 249-28062 Cameri (NO) Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    VIRUPAKSHA ORGANICS LIMITED

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 51686-0012

    Start Marketing Date : 2007-10-16

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Wavelength Enterprises LTD

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 58175-0606

    Start Marketing Date : 2015-05-15

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    Seqens Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dipharma Francis Srl

    Italy
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Dipharma Francis Srl

    Italy
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 46438-0644

    Start Marketing Date : 2005-10-13

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Glenmark Life Sciences Limited

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Glenmark Life Sciences Limited

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 66039-930

    Start Marketing Date : 2016-09-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    HAMARI PFST, Ltd.

    Japan
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    HAMARI PFST, Ltd.

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 51557-001

    Start Marketing Date : 2014-06-06

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER, FOR SOLUTION (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Harman Finochem Limited

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Harman Finochem Limited

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 66064-1024

    Start Marketing Date : 2017-01-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (10kg/10kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Maithri Drugs Private Limited

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Maithri Drugs Private Limited

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 70600-001

    Start Marketing Date : 2016-03-31

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sumitomo Chemical Company, Limited

    Japan
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Sumitomo Chemical Company, Limited

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 68259-1314

    Start Marketing Date : 2014-07-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER, FOR SOLUTION (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Zhejiang Ausun Pharmaceutical Co., ...

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Zhejiang Ausun Pharmaceutical Co., ...

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 76397-006

    Start Marketing Date : 2020-01-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Zhejiang Ausun Pharmaceutical Co., ...

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Zhejiang Ausun Pharmaceutical Co., ...

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EFINACONAZOLE

    NDC Package Code : 76397-018

    Start Marketing Date : 2018-01-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR HUMAN P...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Virupaksha Organics

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the...

    Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the Hyderabad-based company has grown from a single manufacturing unit to four, employing over 1,000 people. The manufacturing units are situated in Kazipally, Pashamylaram, Humnabad and Gandhi Nagar. Virupaksha's manufacturing facility holds FDA approval, reflecting its adherence to stringent standards. With a customer base exceeding 300 and a presence spanning over 70 countries, Virupaksha has established itself as a reputable global player in its field.
    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LGM Pharma

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

    LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Metrochem API Private Limited

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company :

    Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

    Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
    Metrochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Seqens

    France
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling ...

    Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
    Seqens Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Dipharma

    Italy
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Dipharma

    Italy
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Dipharma is a leading European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our custome...

    Dipharma is a leading European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our customers worldwide with a strong and well resourced R&D team, three cGMP facilities in Europe, and offer world-renowned expertise in handling hazardous chemical processes. Our customers can benefit from our broad portfolio of generic Active Pharmaceutical Ingredients and a wide range of advanced technologies available for custom synthesis. They can rely on the highest quality standards, but it does not stop there, they can count on our experience in innovation.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Harman Finochem

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Harman Finochem

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of ...

    Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of which 10 are Essential Drugs as per the WHO Model List. We deliver top quality products to more than 35 countries across the globe. Harman Finochem ensures that its customers worldwide are delighted by receiving APl’s which are safe, efficient and of highest quality. We adhere to principles of cGmp and our team at all levels is committed to achieving this corporate excellence goal.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Maithri Drugs

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Maithri Drugs

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its ex...

    Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research & development and aggressive growth strategies. Our 32 US DMFs and 9 CEPs in a short span attest to our R&D excellence. Maithri's manufacturing facility is located in Hyderabad. This facility is audited and approved by the US FDA. In addition, our facility is certified according to the standards of DCGI, WHO GMP, and ISO 9001:2015 We have a portfolio of 65 products and are continually expanding.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Nifty Labs

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Nifty Labs

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in contro...

    The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in controlling the day to day operations of the company. The company has been focused on manufacturing and marketing of Bulk APIs (Bulk Drugs) and key Intermediates for APIs for Domestic and Global markets. About 60% is catered to domestic market and the rest 40% is catered to exports. The company does have a sister company named “Nifty Pharma Pvt. Ltd. located in Hyderabad focused on manufacturing & marketing of Semi-finished dosage forms.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Synergene Active Ingredients Pvt Lt...

    India
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Synergene Active Ingredients Pvt Lt...

    India
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals...

    Synergene Active Ingredients Pvt.Ltd was incorporated in 2006 and commercial operations began in the same year. The Company is a manufacturer and supplier of Active Pharmaceuticals Ingredients (API'S) for wide range of therapeutic categories. Therapeutic segments of focus are Anti Fungals, Anti Depressants, and Anti Hypertensive. Synergene manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. The company has two manufacturing facilities located at Hyderabad & Vishakhapatnam manufacturing Active Pharmaceutical Ingredients and Intermediates.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Viwit Pharmaceuticals Limited

    China
    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Viwit Pharmaceuticals Limited

    China
    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Efinaconazole

    About the Company : Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical healthcare company dedicated to the development, manufacture and marketing o...

    Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical healthcare company dedicated to the development, manufacture and marketing of innovative products in the fields of Finished Dosage Formulations, Active Pharmaceutical Ingredients and Fine Chemicals. Viwit manufactures all the products based on company’s core technologies, and is dedicated to serve customers for their greater success and healthier living.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"EFINACONAZOLE","year":"2021","qtr":"Q1","strtotime":1612549800,"product":"EFINACONAZOLE (0.036 KGS)","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"GLOBE MEDICAL LLC","customerCountry":"RUSSIA","quantity":"0.04","actualQuantity":"0.036","unit":"KGS","unitRateFc":"9256.4","totalValueFC":"329.8","currency":"USD","unitRateINR":666925,"date":"06-Feb-2021","totalValueINR":"24009.3","totalValueInUsd":"329.8","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"8455567","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-27, AMEERPET, HYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1629657000,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BL H CO, LTD,","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.20","actualQuantity":"200","unit":"GMS","unitRateFc":"18","totalValueFC":"3505.8","currency":"USD","unitRateINR":1300.0989500000001,"date":"23-Aug-2021","totalValueINR":"260019.79","totalValueInUsd":"3505.8","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4040505","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630953000,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"DONG WHA PHARM, CO, LTD,","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.15","actualQuantity":"0.15","unit":"KGS","unitRateFc":"12000","totalValueFC":"1713","currency":"USD","unitRateINR":840000,"date":"07-Sep-2021","totalValueINR":"126000","totalValueInUsd":"1713","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4427939","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632853800,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BL & H CO. LTD.","customerCountry":"KOREA, REPUBLIC OF","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"14000","totalValueFC":"41437.6","currency":"USD","unitRateINR":1016000,"date":"29-Sep-2021","totalValueINR":"3048000","totalValueInUsd":"41437.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4944766","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639333800,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"CHONG KUN DANG PHARM","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"18000","totalValueFC":"3473.6","currency":"USD","unitRateINR":1310000,"date":"13-Dec-2021","totalValueINR":"262000","totalValueInUsd":"3473.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6685784","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639679400,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"KOREA, REPUBLIC OF","quantity":"6.76","actualQuantity":"6.76","unit":"KGS","unitRateFc":"8500","totalValueFC":"57380.6","currency":"USD","unitRateINR":640236.68639053253,"date":"17-Dec-2021","totalValueINR":"4328000","totalValueInUsd":"57380.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6808063","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639679400,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"KOREA, REPUBLIC OF","quantity":"6.90","actualQuantity":"6.9","unit":"KGS","unitRateFc":"8500","totalValueFC":"58587.1","currency":"USD","unitRateINR":640434.78260869556,"date":"17-Dec-2021","totalValueINR":"4419000","totalValueInUsd":"58587.1","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6807903","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639679400,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"KOREA, REPUBLIC OF","quantity":"11.10","actualQuantity":"11.1","unit":"KGS","unitRateFc":"8500","totalValueFC":"94224.6","currency":"USD","unitRateINR":640270.2702702703,"date":"17-Dec-2021","totalValueINR":"7107000","totalValueInUsd":"94224.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6808063","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659724200,"product":"EFINACONAZOLE BATCH NUMBER AEF1220001","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MS,","customerCountry":"KOREA, REPUBLIC OF","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"8500","totalValueFC":"49354.5","currency":"USD","unitRateINR":654500,"date":"06-Aug-2022","totalValueINR":"3927000","totalValueInUsd":"49354.5","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3339807","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661711400,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"HIGHFLY CO. LTD.","customerCountry":"KOREA, REPUBLIC OF","quantity":"8.00","actualQuantity":"8","unit":"KGS","unitRateFc":"9000","totalValueFC":"71210.3","currency":"USD","unitRateINR":708250,"date":"29-Aug-2022","totalValueINR":"5666000","totalValueInUsd":"71210.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3835508","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663266600,"product":"EFINACONAZOLE","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"DONG WHA PHARM. CO. LTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"7.15","actualQuantity":"7.15","unit":"KGS","unitRateFc":"9000","totalValueFC":"63101.2","currency":"USD","unitRateINR":707272.72727272729,"date":"16-Sep-2022","totalValueINR":"5057000","totalValueInUsd":"63101.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4210909","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663525800,"product":"EFINACONAZOLE","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S.","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"12000","totalValueFC":"5690","currency":"USD","unitRateINR":912000,"date":"19-Sep-2022","totalValueINR":"456000","totalValueInUsd":"5690","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4279567","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. Contac, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1671733800,"product":"EFINACONAZOLE","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. CONTAC","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S ...","customerCountry":"KOREA, REPUBLIC OF","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"8500","totalValueFC":"50311.7","currency":"USD","unitRateINR":691000,"date":"23-Dec-2022","totalValueINR":"4146000","totalValueInUsd":"50311.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6391670","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. CONTAC, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678386600,"product":"EFINACONAZOLE ( BATCH NOAEFI220002)","address":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. CONTAC","city":"NAVI MUMBAI","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S,","customerCountry":"KOREA, REPUBLIC OF","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"8500","totalValueFC":"33592.6","currency":"USD","unitRateINR":690750,"date":"10-Mar-2023","totalValueINR":"2763000","totalValueInUsd":"33592.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8373444","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NO.201, DEVAVRATA SECTOR 17, VASHI, NAVI MUMBAI - 400705. CONTAC, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678732200,"product":"EFINACONAZOLE (DRUG AND DRUGS INTERMEDIA","address":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,","city":"MUMBAI,MAHARASHTRA","supplier":"HARMAN FINOCHEM","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"TO ORDER","customerCountry":"JAPAN","quantity":"0.60","actualQuantity":"0.6","unit":"KGS","unitRateFc":"15250","totalValueFC":"9082","currency":"USD","unitRateINR":1245000,"date":"14-Mar-2023","totalValueINR":"747000","totalValueInUsd":"9082","indian_port":"BOMBAY AIR","hs_no":"29333990","bill_no":"8468701","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"107A,VINAY BHAVYA COMPLEX,159A, C. S.T ROAD, KALINA SANTACRUZ EAST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680114600,"product":"EFINACONAZOLE - BATCH NO: HDP230025","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"HIGHFLY CO. LTD.","customerCountry":"KOREA, REPUBLIC OF","quantity":"11.00","actualQuantity":"11","unit":"KGS","unitRateFc":"9000","totalValueFC":"98540.6","currency":"USD","unitRateINR":736818.18181818177,"date":"30-Mar-2023","totalValueINR":"8105000","totalValueInUsd":"98540.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8946072","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703788200,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"KOREA, REPUBLIC OF","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"8500","totalValueFC":"84319.2","currency":"USD","unitRateINR":701900,"date":"29-Dec-2023","totalValueINR":"7019000","totalValueInUsd":"84319.2","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"6397031","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709058600,"product":"EFINACONAZOLE BATCH NO:HDP240008","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"KOREA, REPUBLIC OF","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"8500","totalValueFC":"252367.6","currency":"USD","unitRateINR":697996.5656666666,"date":"28-Feb-2024","totalValueINR":"20939896.97","totalValueInUsd":"252367.6","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"7907914","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710354600,"product":"EFINACONAZOLE","address":"NO.201, DEVAVRATA SECTOR 17,,VASHI","city":"NAVI MUMBAI,MAHARASHTRA","supplier":"SOLARA ACTIVE PHARMA SCIENCES","supplierCountry":"INDIA","foreign_port":"MONTEVIDEO -","customer":"M\/S","customerCountry":"URUGUAY","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"7445","totalValueFC":"21760.1","currency":"USD","unitRateINR":602290,"date":"14-Mar-2024","totalValueINR":"1806870","totalValueInUsd":"21760.1","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"8324947","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"URUGAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"NO.201, DEVAVRATA SECTOR 17,,VASHI, NAVI MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721932200,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"DONG WHA PHARM. CO. LTD","customerCountry":"REPUBLIC OF KOREA","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"8500","totalValueFC":"126165.1","currency":"USD","unitRateINR":703085.26666666672,"date":"26-Jul-2024","totalValueINR":"10546279","totalValueInUsd":"126165.1","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2708920","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"REPUBLIC OF KOREA","quantity":"15.75","actualQuantity":"15.75","unit":"KGS","unitRateFc":"7820","totalValueFC":"121905.5","currency":"USD","unitRateINR":646997.47936507943,"date":"31-Jul-2024","totalValueINR":"10190210.3","totalValueInUsd":"121905.5","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2838352","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"EFINACONAZOLE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"GENUONE SCIENCES","customerCountry":"REPUBLIC OF KOREA","quantity":"32.25","actualQuantity":"32.25","unit":"KGS","unitRateFc":"7820","totalValueFC":"249616","currency":"USD","unitRateINR":646997.4790697674,"date":"31-Jul-2024","totalValueINR":"20865668.7","totalValueInUsd":"249616","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2838352","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""}]
    06-Feb-2021
    31-Jul-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search